FDA announced it has awarded 510(k) clearance for expanded indications of the Masimo O3 Regional Oximetry System to include various delta hemoglobin parameters (ΔcHb, ΔHHb and ΔO 2 Hb) to display ...

The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.

This monograph details the clinical efficacy and safety of TNX-102 SL, a sublingual formulation of cyclobenzaprine that targets nonrestorative sleep and modulates centralized pain, as a treatment for ...

Current Evidence-Based Airway Management in Pediatric Anesthesia Clinical research has created evidence-based guidelines and approaches to pediatric airway management that will improve outcomes. JULY ...